Sleep disorders in pregnancy

Clinics in Chest Medicine

Volumn 35, Issue 3, 2014, Pages 571-587

  Oyiengo, Dennis ^a   Louis, Mariam ^b   Hott, Beth ^c   Bourjeily, Ghada ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

Circadian rhythm; Insomnia; Narcolepsy; Pregnancy; Restless legs syndrome; Sleep disordered breathing

Indexed keywords

AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; ARMODAFINIL; BROMOCRIPTINE; CABERGOLINE; CAFFEINE; CARBAMAZEPINE; CLONAZEPAM; CLONIDINE; DIPHENHYDRAMINE; DOXEPIN; GABAPENTIN; LEVODOPA; METHYLPHENIDATE; MODAFINIL; OXYBATE SODIUM; OXYCODONE; PRAMIPEXOLE; PREGABALIN; RAMELTEON; ROPINIROLE; ROTIGOTINE; TEMAZEPAM; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZALEPLON; ZOLPIDEM; ZOPICLONE;

BLEEDING; CESAREAN SECTION; CIRCADIAN RHYTHM SLEEP DISORDER; COGNITIVE THERAPY; CRANIOFACIAL MALFORMATION; DIET RESTRICTION; DISEASE PREDISPOSITION; FEMALE; FETUS OUTCOME; HUMAN; HYPERTENSION; INSOMNIA; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; NARCOLEPSY; NEURAL TUBE DEFECT; NONHUMAN; OFF LABEL DRUG USE; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP TIME; SMOKING CESSATION; SYSTEMATIC REVIEW; TERATOGENICITY;

CIRCADIAN RHYTHM; INSOMNIA; NARCOLEPSY; PREGNANCY; RESTLESS LEGS SYNDROME; SLEEP-DISORDERED BREATHING;

ANIMALS; CHRONOBIOLOGY DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; NARCOLEPSY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RESTLESS LEGS SYNDROME; SLEEP; SLEEP APNEA SYNDROMES; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84906791214     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2014.06.012     Document Type: Review

References (175)

1. American Academy of Sleep Medicine. International classification of sleep disorders, revised: Diagnostic and coding manual 2001, American Academy of Sleep Medicine, Chicago, Illinois.
2. Bourjeily G., Mohsenin V. Sleep physiology in pregnancy. Pulmonary problems in pregnancy 2009, 37-55. Humana Press, New York. K. Rosene-Montella, G. Bourjeily (Eds.).
3. Habr F., Raker C., Lin C.L., et al. Predictors of gastroesophageal reflux symptoms in pregnant women screened for sleep disordered breathing: A secondary analysis. Clin Res Hepatol Gastroenterol 2013, 37(1):93-99.
4. Parboosingh J., Doig A. Studies of nocturia in normal pregnancy. J Obstet Gynaecol Br Commonw 1973, 80(10):888-895.
5. Izci B., Riha R.L., Martin S.E., et al. The upper airway in pregnancy and pre-eclampsia. Am J Respir Crit Care Med 2003, 167:137-140.
6. Pilkington S., Carli F., Dakin M.J., et al. Increase in Mallampati score during pregnancy. Br J Anaesth 1995, 74:638-642.
7. Camann W.R., Ostheimer G.W. Physiological adaptations during pregnancy. Int Anesthesiol Clin 1990, 28:2-10.
8. Hegewald M.J., Crapo R.O. Respiratory physiology in pregnancy. Clin Chest Med 2011, 32:1-13.
9. Bourjeily G., Raker C.A., Chalhoub M., et al. Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing. Eur Respir J 2010, 36:849-855.
10. Louis J.M., Auckley D., Sokol R.J., et al. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol 2010, 202:261.e1-261.e5.
11. Bourjeily G., El Sabbagh R., Sawan P., et al. Epworth Sleepiness Scale scores and adverse pregnancy outcomes. Sleep Breath 2013, 17:1179-1186.
12. Chen Y.H., Kang J.H., Lin C.C., et al. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol 2012, 206:136.e1-136.e5.
13. Reutrakul S., Zaidi N., Wroblewski K., et al. Sleep disturbances and their relationship to glucose tolerance in pregnancy. Diabetes Care 2011, 34:2454-2457.
14. Reutrakul S., Zaidi N., Wroblewski K., et al. Interactions between pregnancy, obstructive sleep apnea, and gestational diabetes mellitus. JClin Endocrinol Metab 2013, 98:4195-4202.
15. Franklin K.A., Holmgren P.A., Jonsson F., et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000, 117:137-141.
16. Micheli K., Komninos I., Bagkeris E., et al. Sleep patterns in late pregnancy and risk of preterm birth and fetal growth restriction. Epidemiology 2011, 22:738-744.
17. Calaora-Tournadre D., Ragot S., Meurice J.C., et al. Obstructive sleep apnea syndrome during pregnancy: prevalence of main symptoms and relationship with pregnancy-induced hypertension and intra-uterine growth retardation. Rev Med Interne 2006, 27:291-295. [in French].
18. Leung P.L., Hui D.S., Leung T.N., et al. Sleep disturbances in Chinese pregnant women. BJOG 2005, 112:1568-1571.
19. Loube D.I., Poceta J.S., Morales M.C., et al. Self-reported snoring in pregnancy. Association with fetal outcome. Chest 1996, 109:885-889.
20. Tauman R., Many A., Deutsch V., et al. Maternal snoring during pregnancy is associated with enhanced fetal erythropoiesis-a preliminary study. Sleep Med 2011, 12:518-522.
21. Charbonneau M., Falcone T., Cosio M.G., et al. Obstructive sleep apnea during pregnancy. Therapy and implications for fetal health. Am Rev Respir Dis 1991, 144:461-463.
22. Joel-Cohen S.J., Schoenfeld A. Fetal response toperiodic sleep apnea: a new syndrome in obstetrics. Eur J Obstet Gynecol Reprod Biol 1978, 8:77-81.
23. Olivarez S.A., Maheshwari B., McCarthy M., et al. Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring. Am J Obstet Gynecol 2010, 202:552.e1-552.e7.
24. Facco F.L., Liu C.S., Cabello A.A., et al. Sleep-disordered breathing: a risk factor for adverse pregnancy outcomes?. Am J Perinatol 2012, 29:277-282.
25. Bourjeily G., Barbara N., Larson L., et al. Clinical manifestations of obstructive sleep apnoea in pregnancy: more than snoring and witnessed apnoeas. JObstet Gynaecol 2012, 32:434-438.
26. Guilleminault C., Kreutzer M., Chang J.L. Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med 2004, 5:43-51.
27. Bourjeily G., Habr F., Miller M.A., et al. Symptoms of sleep-disordered breathing, BMI and pregnancy outcomes. Chest 2007, 132(4):463a.
28. Coleman R.M. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. Sleeping and waking disorders: indications and techniques 1982, 265-295. Addison-Wesley, Menlo Park (CA). C. Guilleminault (Ed.).
29. Ohayon M.M., O'Hara R., Vitiello M.V. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 2012, 16:283-295.
30. Phillips B., Young T., Finn L., et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000, 160:2137-2141.
31. Chen P.H., Liou K.C., Chen C.P., et al. Risk factors and prevalence rate of restless legs syndrome among pregnant women in Taiwan. Sleep Med 2012, 13:1153-1157.
32. Manconi M., Govoni V., De Vito A., et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004, 5:305-308.
33. Harano S., Ohida T., Kaneita Y., et al. Prevalence of restless legs syndrome with pregnancy and the relationship with sleep disorders in the Japanese large population. Sleep Biol Rhythms 2008, 6:102-109.
34. Suzuki K., Ohida T., Sone T., et al. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems. Sleep 2003, 26:673-677.
35. Manconi M., Govoni V., De Vito A., et al. Restless legs syndrome and pregnancy. Neurology 2004, 63:1065-1069.
36. Sikandar R., Khealani B.A., Wasay M. Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan. Sleep Med 2009, 10:676-678.
37. Tunc T., Karadag Y.S., Dogulu F., et al. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 2007, 22:627-631.
38. Alves D.A., Carvalho L.B., Morais J.F., et al. Restless legs syndrome during pregnancy in Brazilian women. Sleep Med 2010, 11:1049-1054.
39. Facco F.L., Kramer J., Ho K.H., et al. Sleep disturbances in pregnancy. Obstet Gynecol 2010, 115:77-83.
40. Uglane M.T., Westad S., Backe B. Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis. Acta Obstet Gynecol Scand 2011, 90:1046-1048.
41. Gambling L., Kennedy C., McArdle H.J. Iron and copper in fetal development. Semin Cell Dev Biol 2011, 22:637-644.
42. Gambling L., Czopek A., Andersen H.S., et al. Fetal iron status regulates maternal iron metabolism during pregnancy in the rat. Am J Physiol Regul Integr Comp Physiol 2009, 296:R1063-R1070.
43. Fosset C., McGaw B.A., Abramovich D., et al. Interrelations between ceruloplasmin and Fe status during human pregnancy. Biol Trace Elem Res 2004, 98:1-12.
44. Swensen A.R., Harnack L.J., Ross J.A. Nutritional assessment of pregnant women enrolled in the Special Supplemental Program for Women, Infants, and Children (WIC). JAm Diet Assoc 2001, 101:903-908.
45. Aul E.A., Davis B.J., Rodnitzky R.L. The importance of formal serum iron studies in the assessment of restless legs syndrome. Neurology 1998, 51:912.
46. Sun E.R., Chen C.A., Ho G., et al. Iron and the restless legs syndrome. Sleep 1998, 21:371-377.
47. Botez M.I., Lambert B. Folate deficiency and restless-legs syndrome in pregnancy. NEngl J Med 1977, 297:670.
48. Lee K.A., Zaffke M.E., Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. JWomens Health Gend Based Med 2001, 10:335-341.
49. Kipp M., Karakaya S., Pawlak J., et al. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors. Front Neuroendocrinol 2006, 27:376-390.
50. Dzaja A., Wehrle R., Lancel M., et al. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep 2009, 32:169-174.
51. Hubner A., Krafft A., Gadient S., et al. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013, 80:738-742.
52. Neau J.P., Marion P., Mathis S., et al. Restless legs syndrome and pregnancy: follow-up of pregnant women before and after delivery. Eur Neurol 2010, 64:361-366.
53. Batool-Anwar S., Malhotra A., Forman J., et al. Restless legs syndrome and hypertension in middle-aged women. Hypertension 2011, 58:791-796.
54. Benediktsdottir B., Janson C., Lindberg E., et al. Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 2010, 11:1043-1048.
55. Ramirez J.O., Cabrera S.A., Hidalgo H., et al. Is preeclampsia associated with restless legs syndrome?. Sleep Med 2013, 14:894-896.
56. Baughman K.R., Bourguet C.C., Ober S.K. Gender differences in the association between antidepressant use and restless legs syndrome. Mov Disord 2009, 24:1054-1059.
57. Kim S.W., Shin I.S., Kim J.M., et al. Factors potentiating the risk of mirtazapine-associated restless legs syndrome. Hum Psychopharmacol 2008, 23:615-620.
58. Rottach K.G., Schaner B.M., Kirch M.H., et al. Restless legs syndrome as side effect of second generation antidepressants. JPsychiatr Res 2008, 43:70-75.
59. Brown L.K., Dedrick D.L., Doggett J.W., et al. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005, 6:443-450.
60. Leutgeb U., Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res 2002, 7:368-378.
61. Aurora R.N., Kristo D.A., Bista S.R., et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012, 35:1039-1062.
62. Reproductive Toxicology Center. Reprotox. Available at: . Accessed November 15, 2013. http://www.reprotox.org/.
63. Hale TW. Medications and mothers' milk. 2000. Available at: . 9th Retrieved November 22, 2013. http://www.medsmilk.com/drugs/.
64. Schneider J., Krafft A., Bloch A., et al. Iron infusion in restless legs syndrome in the third trimester of pregnancy. Sleep Med 2011, 12:S17-S18.
65. National Sleep Foundation. "Sleep America Polls. 2007 Women and Sleep." 2007. Available at: . Retrieved November 21, 2013. http://ww.sleepfoundation.org/article/sleep-america-polls/2007-women-and-sleep.
66. Lee K.A., Zaffke M.E., McEnany G. Parity and sleep patterns during and after pregnancy. Obstet Gynecol 2000, 95:14-18.
67. Wilson D.L., Barnes M., Ellett L., et al. Decreased sleep efficiency, increased wake after sleep onset and increased cortical arousals in late pregnancy. Aust N Z J Obstet Gynaecol 2011, 51:38-46.
68. Hedman C., Pohjasvaara T., Tolonen U., et al. Effects of pregnancy on mothers' sleep. Sleep Med 2002, 3:37-42.
69. Mindell J.A., Jacobson B.J. Sleep disturbances during pregnancy. JObstet Gynecol Neonatal Nurs 2000, 29:590-597.
70. Elek S.M., Hudson D.B., Fleck M.O. Expectant parents' experience with fatigue and sleep during pregnancy. Birth 1997, 24:49-54.
71. Hertz G., Fast A., Feinsilver S.H., et al. Sleep in normal late pregnancy. Sleep 1992, 15:246-251.
72. Lee K.A., DeJoseph J.F. Sleep disturbances, vitality, and fatigue among a select group of employed childbearing women. Birth 1992, 19:208-213.
73. Lee K.A. Sleep dysfunction in women and its management. Curr Treat Options Neurol 2006, 8:376-386.
74. Dorheim S.K., Bjorvatn B., Eberhard-Gran M. Insomnia and depressive symptoms in late pregnancy: a population-based study. Behav Sleep Med 2012, 10:152-166.
75. Tsai S.Y., Kuo L.T., Lee C.N., et al. Reduced sleep duration and daytime naps in pregnant women in Taiwan. Nurs Res 2013, 62:99-105.
76. Fernandez-Alonso A.M., Trabalon-Pastor M., Chedraui P., et al. Factors related to insomnia and sleepiness in the late third trimester of pregnancy. Arch Gynecol Obstet 2012, 286:55-61.
77. Ko H., Shin J., Kim M.Y., et al. Sleep disturbances in Korean pregnant and postpartum women. JPsychosom Obstet Gynaecol 2012, 33:85-90.
78. Fung J, Messerlian G, Curran P, etal. Obstructive sleep apnea is associated with alterations in markers of feto-placental wellbeing. Accepted as oral presentation. European Respiratory Society Annual Congress. Barcelona, Spain, September 7-11, 2013.
79. Pien G.W., Schwab R.J. Sleep disorders during pregnancy. Sleep 2004, 27:1405-1417.
80. Bourjeily G., Raker C., Chalhoub M., et al. Excessive daytime sleepiness in late pregnancy may not always be normal: results from a cross-sectional study. Sleep Breath 2013, 17:735-740.
81. Bei B., Milgrom J., Ericksen J., et al. Subjective perception of sleep, but not its objective quality, is associated with immediate postpartum mood disturbances in healthy women. Sleep 2010, 33:531-538.
82. Dorheim S.K., Bondevik G.T., Eberhard-Gran M., et al. Sleep and depression in postpartum women: a population-based study. Sleep 2009, 32:847-855.
83. Goyal D., Gay C., Lee K. Fragmented maternal sleep is more strongly correlated with depressive symptoms than infant temperament at three months postpartum. Arch Womens Ment Health 2009, 12:229-237.
84. Marques M., Bos S., Soares M.J., et al. Is insomnia in late pregnancy a risk factor for postpartum depression/depressive symptomatology?. Psychiatry Res 2011, 186:272-280.
85. Swanson L.M., Pickett S.M., Flynn H., et al. Relationships among depression, anxiety, and insomnia symptoms in perinatal women seeking mental health treatment. JWomens Health (Larchmt) 2011, 20:553-558.
86. Okun M.L., Hanusa B.H., Hall M., et al. Sleep complaints in late pregnancy and the recurrence of postpartum depression. Behav Sleep Med 2009, 7:106-117.
87. Khazaie H., Ghadami M.R., Knight D.C., et al. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial. Psychiatry Res 2013, 210(3):901-905.
88. Swanson L.M., Flynn H., Adams-Mundy J.D., et al. An open pilot of cognitive-behavioral therapy for insomnia in women with postpartum depression. Behav Sleep Med 2013, 11:297-307.
89. Lee K.A., Gay C.L. Sleep in late pregnancy predicts length of labor and type of delivery. Am J Obstet Gynecol 2004, 191:2041-2046.
90. Naghi I., Keypour F., Ahari S.B., et al. Sleep disturbance in late pregnancy and type and duration of labour. JObstet Gynaecol 2011, 31:489-491.
91. Zafarghandi N., Hadavand S., Davati A., et al. The effects of sleep quality and duration in late pregnancy on labor and fetal outcome. JMatern Fetal Neonatal Med 2012, 25:535-537.
92. Klebanoff M.A., Shiono P.H., Rhoads G.G. Outcomes of pregnancy in a national sample of resident physicians. NEngl J Med 1990, 323:1040-1045.
93. Osborn L.M., Harris D.L., Reading J.C., et al. Outcome of pregnancies experienced during residency. JFam Pract 1990, 31:618-622.
94. Okun M.L., Schetter C.D., Glynn L.M. Poor sleep quality is associated with preterm birth. Sleep 2011, 34:1493-1498.
95. Okun M.L., Hall M., Coussons-Read M.E. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod Sci 2007, 14:560-567.
96. Okun M.L., Coussons-Read M.E. Sleep disruption during pregnancy: how does it influence serum cytokines?. JReprod Immunol 2007, 73:158-165.
97. Okun M.L., Luther J.F., Wisniewski S.R., et al. Disturbed sleep and inflammatory cytokines in depressed and nondepressed pregnant women: an exploratory analysis of pregnancy outcomes. Psychosom Med 2013, 75:670-681.
98. Wikner B.N., Kallen B. Are hypnotic benzodiazepine receptor agonists teratogenic in humans?. JClin Psychopharmacol 2011, 31:356-359.
99. Longstreth W.T., Koepsell T.D., Ton T.G., et al. The epidemiology of narcolepsy. Sleep 2007, 30:13-26.
100. Burgess C.R., Scammell T.E. Narcolepsy: neural mechanisms of sleepiness and cataplexy. JNeurosci 2012, 32:12305-12311.
101. Saper C.B., Chou T.C., Scammell T.E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001, 24:726-731.
102. Scammell T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003, 53:154-166.
103. Chemelli R.M., Willie J.T., Sinton C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
104. Sakurai T., Amemiya A., Ishii M., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
105. Peyron C., Faraco J., Rogers W., et al. Amutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000, 6:991-997.
106. Dall'Aglio C., Pascucci L., Mercati F., et al. Immunohistochemical detection of the orexin system in the placenta of cats. Res Vet Sci 2012, 92:362-365.
107. Maurovich-Horvat E., Kemlink D., Hogl B., et al. Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies. JSleep Res 2013, 22:496-512.
108. Morgenthaler T.I., Kapur V.K., Brown T., et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007, 30:1705-1711.
109. Maurovich-Horvat E., Tormasiova M., Slonkova J., et al. Assessment of pregnancy outcomes in Czech and Slovak women with narcolepsy. Med Sci Monit 2010, 16:SR35-SR40.
110. Ping L.S., Yat F.S., Kwok W.Y. Status cataplecticus leading to the obstetric complication of prolonged labor. JClin Sleep Med 2007, 3:56-57.
111. Thorpy M., Zhao C.G., Dauvilliers Y. Management of narcolepsy during pregnancy. Sleep Med 2013, 14:367-376.
112. Shields N., Muza R., Kosky C., et al. An investigation into the use of stimulant therapy during pregnancy. Sleep Disord 2012, 2012:308952.
113. Straif K., Baan R., Grosse Y., et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007, 8:1065-1066.
114. De Bacquer D., Van Risseghem M., Clays E., et al. Rotating shift work and the metabolic syndrome: a prospective study. Int J Epidemiol 2009, 38:848-854.
115. Scheer F.A., Hilton M.F., Mantzoros C.S., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009, 106:4453-4458.
116. Bisanti L., Olsen J., Basso O., et al. Shift work and subfecundity: a European multicenter study. European Study Group on Infertility and Subfecundity. JOccup Environ Med 1996, 38:352-358.
117. Lauria L., Ballard T.J., Caldora M., et al. Reproductive disorders and pregnancy outcomes among female flight attendants. Aviat Space Environ Med 2006, 77:533-539.
118. Labyak S., Lava S., Turek F., et al. Effects of shiftwork on sleep and menstrual function in nurses. Health Care Women Int 2002, 23:703-714.
119. Endo A., Watanabe T. Effects of non-24-hour days on reproductive efficacy and embryonic development in mice. Gamete Res 1989, 22:435-441.
120. Varcoe T.J., Wight N., Voultsios A., et al. Chronic phase shifts of the photoperiod throughout pregnancy programs glucose intolerance and insulin resistance in the rat. PLoS One 2011, 6:e18504.
121. Zhu J.L., Hjollund N.H., Andersen A.M., et al. Shift work, job stress, and late fetal loss: the National Birth Cohort in Denmark. JOccup Environ Med 2004, 46:1144-1149.
122. Lin Y.C., Chen M.H., Hsieh C.J., et al. Effect of rotating shift work on childbearing and birth weight: a studyof women working in a semiconductor manufacturing factory. World J Pediatr 2011, 7:129-135.
123. Bonzini M., Palmer K.T., Coggon D., et al. Shift work and pregnancy outcomes: a systematic review with meta-analysis of currently available epidemiological studies. BJOG 2011, 118:1429-1437.
124. Porkka-Heiskanen T., Zitting K.M., Wigren H.K. Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiol (Oxf) 2013, 208:311-328.
125. van Amelsvoort L.G., Schouten E.G., Kok F.J. Duration of shiftwork related to body mass index and waist to hip ratio. Int J Obes Relat Metab Disord 1999, 23:973-978.
126. Lange T., Dimitrov S., Fehm H.L., et al. Shift of monocyte function toward cellular immunity during sleep. Arch Intern Med 2006, 166:1695-1700.
127. Irwin M., McClintick J., Costlow C., et al. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 1996, 10:643-653.
128. Irwin M.R., Wang M., Campomayor C.O., et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006, 166:1756-1762.
129. Haelterman E., Marcoux S., Croteau A., et al. Population-based study on occupational risk factors for preeclampsia and gestational hypertension. Scand J Work Environ Health 2007, 33:304-317.
130. Chang P.J., Chu L.C., Hsieh W.S., et al. Working hours and risk of gestational hypertension and pre-eclampsia. Occup Med (Lond) 2010, 60:66-71.
131. Ditisheim A.J., Dibner C., Philippe J., et al. Biological rhythms and preeclampsia. Front Endocrinol (Lausanne) 2013, 4:47.
132. Sharkey K.M., Pearlstein T.B., Carskadon M.A. Circadian phase shifts and mood across the perinatal period in women with a history of major depressive disorder: a preliminary communication. JAffect Disord 2013, 150:1103-1108.
133. Dodd J.M., Crowther C.A., Robinson J.S. Morning compared with evening induction of labor: a nested randomized controlled trial. A nested randomized controlled trial. Obstet Gynecol 2006, 108:350-360.
134. Bakker J.J., van der Goes B.Y., Pel M., et al. Morning versus evening induction of labour for improving outcomes. Cochrane Database Syst Rev 2013, (2). CD007707.
135. Dostal M., Felberg M., Weber-Schoendorfer C., et al. Treatment of restless legs syndrome during pregnancy. Reprod Toxicol 2010, 30:236-237.
136. Tanase H., Hirose K., Shimada K., et al. The safety test of L-DOPA. II. Effect of L-DOPA on the development of pre- and post natal offsprings of experimental animals. Sankyo Kenyusho Nempo 1970, 22:165-186.
137. Staples R.E., Mattis P.A. Teratology of L-dopa. Teratology 1973, 8:238. [abstract].
138. Samojlik E., Khing O.J., Chang M.C. Effects of dopamine on reproductive processes and fetal development in rats. Am J Obstet Gynecol 1969, 104:578-585.
139. Clark R.B., Brunner J.A. Dopamine for the treatment of spinal hypotension during cesarean section. Anesthesiology 1980, 53:514-517.
140. Broussard C.S., Rasmussen S.A., Reefhuis J., et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011, 204:314.e1-314.e11.
141. Bracken M.B., Holford T.R. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981, 58:336-344.
142. Heinonen O.P., Slone D., Shapiro S. Birth defects and drugs in pregnancy 1977, Pub. Sciences Group, Littleton (MA).
143. Schick B., Hom M., Tolosa G., et al. Preliminary analysis of first trimester exposure to oxycodone and hydrocodone. Reprod Toxicol 1996, 10:162.
144. Huisjes H.J., Hadders-Algra M., Touwen B.C. Is clonidine a behavioural teratogen in the human?. Early Hum Dev 1986, 14:43-48.
145. Fisher J.B., Edgren B.E., Mammel M.C., et al. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol 1985, 66:34S-35S.
146. Birnbaum C.S., Cohen L.S., Bailey J.W., et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 1999, 104:e11.
147. Darwish M., Martin P.T., Cevallos W.H., et al. Rapid disappearance of zaleplon from breast milk after oral administration to lactating women. JClin Pharmacol 1999, 39:670-674.
148. Wang L.H., Lin H.C., Lin C.C., et al. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther 2010, 88:369-374.
149. Pons G., Francoual C., Guillet P., et al. Zolpidem excretion in breast milk. Eur J Clin Pharmacol 1989, 37:245-248.
150. American Academy of Pediatrics Committee on Drugs Transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776-789.
151. Diav-Citrin O., Okotore B., Lucarelli K., et al. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. Am J Perinatol 1999, 16:157-160.
152. Stephens S., Wilson G., Gilfillan C., et al. Preliminary data on therapeutic exposure to zopiclone during pregnancy. Reprod Toxicol 2008, 26:73-74.
153. Mathieu O.M., Thompson M., Leplaya M., et al. Case report: in utero exposure and safe breastfeeding in two premature twins of a chronically treated mother with high doses of zopiclone. Fundam Clin Pharmacol 2010, 24:424. [abstract].
154. Takeda Pharmaceuticals America Inc. Micromedex Healthcare Series [intranet database] Version 5.1. Greenwood Village (CO): Thomson Healthcare. Available at: . Retrieved July 1, 2014. http://rxdrugsinfo.com/drug-info-label/rozerem.
155. Greenberg G., Inman W.H., Weatherall J.A., et al. Maternal drug histories and congenital abnormalities. Br Med J 1977, 2:853-856.
156. Winship K.A., Cahal D.A., Weber J.C., et al. Maternal drug histories and central nervous system anomalies. Arch Dis Child 1984, 59:1052-1060.
157. Einarson A., Choi J., Einarson T.R., et al. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 2009, 54:242-246.
158. Einarson A., Bonari L., Voyer-Lavigne S., et al. Amulticentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatry 2003, 48:106-110.
159. McElhatton P.R., Garbis H.M., Eléfant E., et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 1996, 10:285-294.
160. Newport D.J., Ritchie J.C., Knight B.T., et al. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure. JClin Psychiatry 2009, 70:1304-1310.
161. Bennett P.N. Drugs and human lactation: a guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals, and environmental and occupational chemicals in human milk 1988, Elsevier, New York.
162. Anderka M., Mitchell A.A., Louik C., et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol 2012, 94:22-30.
163. Saxen I. Letter: Cleft palate and maternal diphenhydramine intake. Lancet 1974, 1:407-408.
164. Gilboa S.M., Strickland M.J., Olshan A.F., et al. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol 2009, 85:137-150.
165. Kargas G.A., Kargas S.A., Bruyere H.J., et al. Perinatal mortality due to interaction of diphenhydramine and temazepam. NEngl J Med 1985, 313:1417-1418.
166. Little B.B., Snell L.M., Gilstrap L.C. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988, 72:541-544.
167. Milkovich L., van der Berg B.J. Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol 1977, 129:637-642.
168. Nora J.J., Trasler D.G., Fraser F.C. Malformations in mice induced by dexamphetamine sulphate. Lancet 1965, 2:1021-1022.
169. American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women Committee Opinion No. 479: methamphetamine abuse in women of reproductive age. Obstet Gynecol 2011, 117:751-755.
170. Dideriksen D., Pottegard A., Hallas J., et al. First trimester in utero exposure to methylphenidate. Basic Clin Pharmacol Toxicol 2013, 112:73-76.
171. Laget-Corsin L., Baroche J. Anesthesia with sodium gamma-hydroxybutyrate in cesarean section. Anesth Analg (Paris) 1972, 29:43-49. [in French].
172. Lennestal R., Kallen B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. JClin Psychopharmacol 2007, 27:607-613.
173. Kallen B., Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006, 21:221-222.
174. Berlin C.M. Advances in pediatric pharmacology and toxicology. Adv Pediatr 1995, 42:593-629.
175. Webster P.A. Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet 1973, 2:318-319.